blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0368339

EP0368339 - Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.04.1994
Database last updated on 24.04.2024
Most recent event   Tooltip23.04.1994No opposition filed within time limitpublished on 15.06.1994 [1994/24]
Applicant(s)For all designated states
Eisai Co., Ltd.
6-10, Koishikawa 4-chome Bunkyo-ku
Tokyo / JP
For all designated states
Sansho Co., Ltd.
13-24, Funado 4-chome Itabashi-ku
Tokyo / JP
[N/P]
Former [1990/20]For all designated states
Eisai Co., Ltd.
6-10, Koishikawa 4-chome Bunkyo-ku
Tokyo / JP
For all designated states
Sansho Co., Ltd.
13-24, Funado 4-chome
Itabashi-ku Tokyo / JP
Inventor(s)01 / Yoshida, Mitsuhiro
201, 2924-3, Uenodai
Fukaya-shi Saitama / JP
02 / Fujimori, Hiroyuki
1034-1, Imai
Honjou-shi Saitama / JP
03 / Asakawa, Hidenori
1034-1, Imai
Honjou-shi Saitama / JP
04 / Kasai, Masayoshi
5-156, Tsutsujigaoka
Kakamigahara-shi Gifu / JP
05 / Kayano, Masanori
9-20, Idogi 1-chome
Ageo-shi Saitama / JP
06 / Osawa, Shigemitsu
2286-12, Suehirocho
Honjou-shi Saitama / JP
[1990/20]
Representative(s)Hansen, Bernd, et al
Hoffmann Eitle Patent- und Rechtsanwälte Postfach 81 04 20
81904 München / DE
[N/P]
Former [1990/20]Hansen, Bernd, Dr.rer.nat., et al
Hoffmann, Eitle & Partner Patentanwälte Postfach 81 04 20
D-81904 München / DE
Application number, filing date89120888.610.11.1989
[1990/20]
Priority number, dateJP1988028542811.11.1988         Original published format: JP 28542888
[1990/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0368339
Date:16.05.1990
Language:EN
[1990/20]
Type: A3 Search report 
No.:EP0368339
Date:19.12.1990
Language:EN
[1990/51]
Type: B1 Patent specification 
No.:EP0368339
Date:23.06.1993
Language:EN
[1993/25]
Search report(s)(Supplementary) European search report - dispatched on:EP29.10.1990
ClassificationIPC:A61K31/505, A61K47/14
[1990/20]
CPC:
A61K31/55 (EP,US); A61K47/14 (EP,US); A61K9/0014 (EP,US);
A61P9/12 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1990/20]
TitleGerman:Bunazosin oder seine Salze enthaltende pharmazeutische Zubereitungen zur perkutanen Verabreichung[1990/20]
English:Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt[1990/20]
French:Compositions pharmaceutiques contenant la bunazosine ou ses sels pour l'administration percutanée[1990/20]
Examination procedure22.01.1991Examination requested  [1991/12]
09.12.1991Despatch of a communication from the examining division (Time limit: M06)
09.06.1992Reply to a communication from the examining division
07.10.1992Despatch of communication of intention to grant (Approval: Yes)
08.12.1992Communication of intention to grant the patent
25.02.1993Fee for grant paid
25.02.1993Fee for publishing/printing paid
Opposition(s)24.03.1994No opposition filed within time limit [1994/24]
Fees paidRenewal fee
28.11.1991Renewal fee patent year 03
31.03.1993Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.11.199204   M06   Fee paid on   31.03.1993
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AP]JP63301822  ;
 [A]EP0254978  (EISAI CO LTD [JP])
 [A]  - J. PHARM. PHARMCAOL., vol. 39, 1987, pages 399-400, J. PHARM. PHARMACOL.; A. KATO et al.: "Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride"
 [AP]  - STN INTERNATIONAL INFORMATION SERVICES SATA BASE: CHEMICAL ABSTRACTS, vol. 111, no. 12, abstract no. 102753a, Columbus, Ohio, US; & JP-A-63 301 822 (EISAI CO., LTD) 08-12-1988, & JP63301822 A 00000000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.